Y-mAbs Therapeutics IncNASDAQ:YMAB
- LAST PRICE11.6000
- TODAY'S CHANGE (%)-0.2500 (-2.1097%)
- Bid / Lots10.0000/ 2
- Ask / Lots12.5500/ 1
- Open / Previous Close11.9500 / 11.8500
- Day Range
- 52 Week Range
- Volume379,958
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | YMAB |
|---|---|---|
| 09:32 ET | 9711 | 11.95 |
| 09:39 ET | 400 | 11.7323 |
| 09:41 ET | 5687 | 11.775 |
| 09:50 ET | 200 | 11.775 |
| 09:52 ET | 100 | 11.81 |
| 09:54 ET | 100 | 11.78 |
| 09:56 ET | 100 | 11.82 |
| 09:59 ET | 100 | 11.82 |
| 10:01 ET | 300 | 11.83 |
| 10:03 ET | 500 | 11.86 |
| 10:06 ET | 100 | 11.87 |
| 10:08 ET | 450 | 11.79 |
| 10:10 ET | 100 | 11.835 |
| 10:12 ET | 200 | 11.79 |
| 10:14 ET | 100 | 11.86 |
| 10:15 ET | 100 | 11.875 |
| 10:17 ET | 300 | 11.85 |
| 10:21 ET | 100 | 11.87 |
| 10:24 ET | 500 | 11.835 |
| 10:26 ET | 3046 | 12.02 |
| 10:28 ET | 1301 | 11.96 |
| 10:30 ET | 100 | 11.98 |
| 10:32 ET | 900 | 11.99 |
| 10:33 ET | 200 | 11.99 |
| 10:35 ET | 1157 | 11.92 |
| 10:37 ET | 800 | 11.8 |
| 10:39 ET | 400 | 11.75 |
| 10:42 ET | 1150 | 11.75 |
| 10:44 ET | 100 | 11.77 |
| 10:46 ET | 500 | 11.77 |
| 10:48 ET | 300 | 11.82 |
| 10:50 ET | 700 | 11.82 |
| 10:51 ET | 3200 | 11.79 |
| 10:53 ET | 1222 | 11.74 |
| 10:57 ET | 3448 | 11.75 |
| 11:00 ET | 934 | 11.75 |
| 11:02 ET | 200 | 11.75 |
| 11:04 ET | 200 | 11.77 |
| 11:06 ET | 200 | 11.74 |
| 11:08 ET | 1563 | 11.74 |
| 11:09 ET | 200 | 11.77 |
| 11:11 ET | 100 | 11.77 |
| 11:18 ET | 2052 | 11.78 |
| 11:22 ET | 300 | 11.75 |
| 11:27 ET | 500 | 11.72 |
| 11:31 ET | 300 | 11.69 |
| 11:36 ET | 100 | 11.72 |
| 11:38 ET | 100 | 11.695 |
| 11:40 ET | 121 | 11.67 |
| 11:42 ET | 1099 | 11.67 |
| 11:44 ET | 100 | 11.6273 |
| 11:45 ET | 200 | 11.67 |
| 11:47 ET | 100 | 11.62 |
| 11:49 ET | 400 | 11.66 |
| 11:54 ET | 2108 | 11.645 |
| 11:56 ET | 800 | 11.61 |
| 11:58 ET | 793 | 11.62 |
| 12:00 ET | 800 | 11.6 |
| 12:02 ET | 700 | 11.56 |
| 12:03 ET | 1582 | 11.615 |
| 12:05 ET | 1104 | 11.57 |
| 12:07 ET | 900 | 11.54 |
| 12:09 ET | 1851 | 11.605 |
| 12:12 ET | 919 | 11.585 |
| 12:14 ET | 1000 | 11.58 |
| 12:16 ET | 2182 | 11.585 |
| 12:18 ET | 239 | 11.64 |
| 12:20 ET | 1213 | 11.63 |
| 12:21 ET | 950 | 11.63 |
| 12:23 ET | 1700 | 11.58 |
| 12:25 ET | 1404 | 11.58 |
| 12:27 ET | 900 | 11.55 |
| 12:30 ET | 1200 | 11.58 |
| 12:32 ET | 900 | 11.56 |
| 12:34 ET | 1275 | 11.56 |
| 12:36 ET | 501 | 11.57 |
| 12:38 ET | 884 | 11.6 |
| 12:39 ET | 1200 | 11.57 |
| 12:41 ET | 1557 | 11.59 |
| 12:43 ET | 661 | 11.58 |
| 12:45 ET | 1124 | 11.565 |
| 12:48 ET | 650 | 11.52 |
| 12:50 ET | 1050 | 11.56 |
| 12:52 ET | 1533 | 11.63 |
| 12:54 ET | 787 | 11.61 |
| 12:56 ET | 1993 | 11.625 |
| 12:57 ET | 1050 | 11.6 |
| 12:59 ET | 600 | 11.605 |
| 01:01 ET | 1199 | 11.61 |
| 01:03 ET | 1306 | 11.6 |
| 01:06 ET | 1526 | 11.63 |
| 01:08 ET | 2284 | 11.69 |
| 01:10 ET | 1813 | 11.75 |
| 01:12 ET | 1096 | 11.745 |
| 01:14 ET | 1574 | 11.745 |
| 01:15 ET | 729 | 11.745 |
| 01:17 ET | 1532 | 11.72 |
| 01:19 ET | 800 | 11.655 |
| 01:21 ET | 600 | 11.645 |
| 01:24 ET | 850 | 11.66 |
| 01:26 ET | 1057 | 11.67 |
| 01:28 ET | 1093 | 11.68 |
| 01:30 ET | 1978 | 11.697 |
| 01:32 ET | 500 | 11.68 |
| 01:33 ET | 1062 | 11.65 |
| 01:35 ET | 650 | 11.6 |
| 01:37 ET | 1550 | 11.67 |
| 01:39 ET | 1150 | 11.667 |
| 01:42 ET | 800 | 11.675 |
| 01:44 ET | 1452 | 11.67 |
| 01:46 ET | 1553 | 11.71 |
| 01:48 ET | 650 | 11.69 |
| 01:50 ET | 1450 | 11.685 |
| 01:51 ET | 798 | 11.71 |
| 01:53 ET | 1957 | 11.715 |
| 01:55 ET | 1000 | 11.71 |
| 01:57 ET | 704 | 11.715 |
| 02:00 ET | 1480 | 11.73 |
| 02:02 ET | 987 | 11.74 |
| 02:04 ET | 700 | 11.69 |
| 02:06 ET | 950 | 11.68 |
| 02:08 ET | 905 | 11.685 |
| 02:09 ET | 1671 | 11.73 |
| 02:11 ET | 600 | 11.7 |
| 02:13 ET | 3676 | 11.705 |
| 02:15 ET | 600 | 11.69 |
| 02:18 ET | 1327 | 11.7 |
| 02:20 ET | 350 | 11.72 |
| 02:22 ET | 1350 | 11.715 |
| 02:24 ET | 414 | 11.7 |
| 02:26 ET | 2074 | 11.71 |
| 02:27 ET | 550 | 11.69 |
| 02:29 ET | 1177 | 11.7 |
| 02:31 ET | 800 | 11.71 |
| 02:33 ET | 1150 | 11.705 |
| 02:36 ET | 1850 | 11.755 |
| 02:38 ET | 900 | 11.74 |
| 02:40 ET | 1150 | 11.74 |
| 02:42 ET | 1088 | 11.71 |
| 02:44 ET | 1250 | 11.725 |
| 02:45 ET | 1400 | 11.735 |
| 02:47 ET | 950 | 11.73 |
| 02:49 ET | 1366 | 11.73 |
| 02:51 ET | 1000 | 11.76 |
| 02:54 ET | 900 | 11.74 |
| 02:56 ET | 2938 | 11.765 |
| 02:58 ET | 422 | 11.74 |
| 03:00 ET | 3079 | 11.81 |
| 03:02 ET | 2068 | 11.77 |
| 03:03 ET | 1250 | 11.7 |
| 03:05 ET | 1456 | 11.68 |
| 03:07 ET | 1760 | 11.68 |
| 03:09 ET | 850 | 11.65 |
| 03:12 ET | 950 | 11.72 |
| 03:14 ET | 1781 | 11.695 |
| 03:16 ET | 1250 | 11.7 |
| 03:18 ET | 2350 | 11.7 |
| 03:20 ET | 1054 | 11.7 |
| 03:21 ET | 1879 | 11.77 |
| 03:23 ET | 1720 | 11.71 |
| 03:25 ET | 1299 | 11.7 |
| 03:27 ET | 1848 | 11.7 |
| 03:30 ET | 1017 | 11.69 |
| 03:32 ET | 1798 | 11.64 |
| 03:34 ET | 2872 | 11.7 |
| 03:36 ET | 1750 | 11.7 |
| 03:38 ET | 2062 | 11.7 |
| 03:39 ET | 2353 | 11.685 |
| 03:41 ET | 2476 | 11.65 |
| 03:43 ET | 2057 | 11.68 |
| 03:45 ET | 3309 | 11.6305 |
| 03:48 ET | 4359 | 11.63 |
| 03:50 ET | 2316 | 11.615 |
| 03:52 ET | 4068 | 11.62 |
| 03:54 ET | 5777 | 11.62 |
| 03:56 ET | 9232 | 11.6 |
| 03:57 ET | 7048 | 11.61 |
| 03:59 ET | 20341 | 11.6 |
May 8, 2024
DJ Y-mAbs Therapeutics Down Over 17%, on Pace for Largest Percent Decrease Since October 2022 -- Data Talk, from 1:15PM ET on Wednesday May 08, 2024 by Dow Jones
1:15PM ET on Wednesday May 08, 2024 by Dow Jones
May 7, 2024
*DJ Y-mAbs Therapeutics 1Q Loss/Shr 15c >YMAB, from 4:05PM ET on Tuesday May 07, 2024 by Dow Jones
4:05PM ET on Tuesday May 07, 2024 by Dow JonesY-mAbs Reports First Quarter 2024 Financial Results and Recent Corporate Developments, from 4:05PM ET on Tuesday May 07, 2024 by Dow Jones
4:05PM ET on Tuesday May 07, 2024 by Dow Jones
Apr 26, 2024
Y-mAbs to Announce First Quarter 2024 Financial and Operating Results on May 7, 2024, from 7:05AM ET on Friday Apr 26, 2024 by Dow Jones
7:05AM ET on Friday Apr 26, 2024 by Dow Jones
Apr 25, 2024
Y-mAbs to Present at 2024 ASCO Annual Meeting, from 4:05PM ET on Thursday Apr 25, 2024 by Dow Jones
4:05PM ET on Thursday Apr 25, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Y-mAbs Therapeutics Inc | 509.0M | -23.4x | --- |
Urogen Pharma Ltd | 477.6M | -3.9x | --- |
Editas Medicine Inc | 462.2M | -2.7x | --- |
Alector Inc | 524.3M | -3.9x | --- |
Zymeworks Inc | 644.8M | -5.1x | --- |
Fate Therapeutics Inc | 443.9M | -2.0x | --- |
Company Information
Y-mAbs Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of radioimmunotherapy and antibody-based therapeutic cancer products. Its technologies include its investigational Self-Assembly DisAssembly (SADA) Pretargeted Radioimmunotherapy Platform and bispecific antibodies generated using the Y-BiClone platform. Its advanced product pipeline includes the anti-GD2 therapy DANYELZA (naxitamab-gqgk), a food and drug administration (FDA)-approved treatment for patients with relapsed or refractory neuroblastoma in the bone or bone marrow after a partial response, minor response or stable disease to prior therapy. DANYELZA is a humanized immunoglobulin G, subtype 1k (IgG1k), monoclonal antibody (mAb), that targets ganglioside GD2, which is expressed in various neuroectoderm derived tumors and sarcomas. Omburtamab targets B7-H3, an immune checkpoint molecule that is expressed in tumor cells of several cancer types.
Contact Information
- Headquarters
- 230 PARK AVENUE, SUITE 3350NEW YORK, NY, United States 10169
- Phone
- 212-847-9841
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- James Healy
- President, Chief Executive Officer, Director
- Michael Rossi
- Vice Chairman of the Board, Chief Business Officer
- Thomas Gad
- Chief Financial Officer, Executive Vice President, Treasurer, Secretary
- Bo Kruse
- Chief Operating Officer, Senior Vice President
- Joris Wilms
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $509.0M |
|---|---|
Revenue (TTM) | $84.5M |
Shares Outstanding | 43.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.66 |
EPS | $-0.50 |
Book Value | $2.31 |
P/E Ratio | -23.4x |
Price/Sales (TTM) | 6.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -29.68% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
